Remeditex Ventures LLC

CIK 1627363 · View on SEC EDGAR ↗

Insider

First SEC filing: Jan. 24, 2018 · Latest: Jan. 24, 2018

On this page

Insider at

Insider transactions

0 buys (P) 0 sells (S) Net: $0 + 6 non-open-market transactions below last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

6 other filings hidden
Date Ticker Code Shares Price Value Owned after Δ own A/D vs now
Jan. 25, 2018 YARW P 100,000 $17.00 $1,700,000 1,582,854 Direct +6.74% Acquired -99.9% (price as of 2026-08-21)

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Derivative holdings (Form 4 Table II)

Options, RSUs and convertible securities reported on Form 4 Table II.

Date Ticker Security Underlying Exercise price Expiration Shares A/D
Jan. 29, 2018 YARW Series C Preferred Stock Common Stock (304,576) — — 821,596 Disposed
Jan. 29, 2018 YARW Series B Preferred Stock Common Stock (871,583) — — 2,351,097 Disposed
Jan. 29, 2018 YARW Series A Preferred Stock Common Stock (2,650) — — 7,150 Disposed

Exercise/conversion price is blank when not applicable (e.g. RSUs).

Initial ownership (Form 3) 5 holdings

Securities held when first becoming an insider, per SEC Form 3.

Date Ticker Security Shares Ownership
Jan. 24, 2018 YARW Common Stock 1,482,854 Direct
Jan. 24, 2018 YARW Series A Preferred Stock→ Common Stock (2,650) 2,650 Direct
Jan. 24, 2018 YARW Series B Preferred Stock→ Common Stock (871,583) 871,583 Direct
Jan. 24, 2018 YARW Series C Preferred Stock→ Common Stock (304,576) 304,576 Direct
Feb. 13, 2017 VRDN Common Stock 2,706,563 Direct